Atrial FDG Uptake: Etiologies, Clinical Significance, and Implications

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Date 2025 Jan 15

PMID 39812941

Authors

Julie Lanctot-Bedard

Hassan Bachir Melhem

Francois Harel

Matthieu Pelletier-Galarneau

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: This review aims to explore the clinical significance of atrial fluorodeoxyglucose (FDG) uptake observed in positron emission tomography (PET) scans, focusing on its association with atrial fibrillation (AF), cardiac sarcoidosis, and myocarditis. We discuss the implications of atrial uptake for patient management and prognosis.

Recent Findings: Recent studies have demonstrated that atrial FDG uptake is frequently present in patients with AF, particularly those with persistent AF, and is linked to increased risks of stroke and poorer outcomes after ablation. In cardiac sarcoidosis, atrial uptake correlates with inflammation and an elevated risk of AF. Additionally, non-granulomatous myocarditis has been associated with localized atrial FDG uptake, necessitating careful differentiation from other causes. : Atrial FDG uptake reflects underlying pathological processes such as inflammation, which can significantly impact patient management and outcomes across various cardiovascular diseases. Recognizing these findings can facilitate early intervention, improve prognosis, and support the development of clear guidelines for clinical practice, emphasizing the need for continued research in this area.

References

Pelletier-Galarneau M, Abikhzer G, Harel F, Dilsizian V . Detection of Native and Prosthetic Valve Endocarditis: Incremental Attributes of Functional FDG PET/CT over Morphologic Imaging. Curr Cardiol Rep. 2020; 22(9):93. DOI: 10.1007/s11886-020-01334-w. View

Xie B, Chen B, Nanna M, Wu J, Zhou Y, Shi L . 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in atrial fibrillation: a pilot prospective study. Eur Heart J Cardiovasc Imaging. 2021; 23(1):102-112. DOI: 10.1093/ehjci/jeab088. View

Sinigaglia M, Mahida B, Piekarski E, Chequer R, Mikail N, Benali K . FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation. Eur J Nucl Med Mol Imaging. 2019; 46(6):1268-1275. DOI: 10.1007/s00259-019-4274-6. View

Wan P, Yu W, Zhai L, Qian B, Zhang F, Liu B . The relationship between right atrial wall inflammation and poor prognosis of atrial fibrillation based on F-FDG positron emission tomography/computed tomography. Quant Imaging Med Surg. 2024; 14(2):1369-1382. PMC: 10895105. DOI: 10.21037/qims-23-1129. View

Xie B, Chen B, Wu J, Liu X, Yang M . Factors relevant to atrial F-fluorodeoxyglucose uptake in atrial fibrillation. J Nucl Cardiol. 2018; 27(5):1501-1512. PMC: 7599132. DOI: 10.1007/s12350-018-1387-4. View

Abohashem S, Aldosoky W, Osborne M . Atrial FDG uptake linked to ischemic stroke in patients without atrial fibrillation. J Nucl Cardiol. 2022; 29(6):3204-3206. PMC: 9596678. DOI: 10.1007/s12350-022-02979-6. View

Fujimoto Y, Matsue Y, Maeda D, Dotare T, Sunayama T, Iso T . Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis. Eur Heart J Open. 2023; 3(5):oead100. PMC: 10578462. DOI: 10.1093/ehjopen/oead100. View

Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y . Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993; 43(7-8):372-6. DOI: 10.1111/j.1440-1827.1993.tb01148.x. View

Perry A, Vuitch F . Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995; 119(2):167-72. View

10.

Hu Y, Chen Y, Lin Y, Chen S . Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015; 12(4):230-43. DOI: 10.1038/nrcardio.2015.2. View

11.

Patel V, Pieper J, Poitrasson-Riviere A, Kopin D, Cascino T, Aaronson K . The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. J Nucl Cardiol. 2021; 29(5):2460-2470. DOI: 10.1007/s12350-021-02780-x. View

12.

Yodogawa K, Fukushima Y, Ando T, Iwasaki Y, Akiyama K, Kumita S . Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis. Int J Cardiol. 2020; 313:55-59. DOI: 10.1016/j.ijcard.2020.04.041. View

13.

Niemela M, Uusitalo V, Poyhonen P, Schildt J, Lehtonen J, Kupari M . Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study. JACC Cardiovasc Imaging. 2022; 15(9):1622-1631. DOI: 10.1016/j.jcmg.2022.02.025. View

14.

Rosenthal D, Fang C, Groh C, Nah G, Vittinghoff E, Dewland T . Association Between Sarcoidosis and Atrial Fibrillation Among Californians Using Medical Care. JACC Clin Electrophysiol. 2021; 7(12):1620-1622. DOI: 10.1016/j.jacep.2021.09.006. View

15.

Sama C, Fongwen N, Chobufo M, Hamirani Y, Mills J, Roberts M . A systematic review and meta-analysis of the prevalence, incidence, and predictors of atrial fibrillation in cardiac sarcoidosis. Int J Cardiol. 2023; 391:131285. DOI: 10.1016/j.ijcard.2023.131285. View

16.

De Bortoli A, Birnie D . Incidence of Atrial Fibrillation in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023; 16(2):262-263. DOI: 10.1016/j.jcmg.2022.10.028. View

17.

Larsen B, Maleszewski J, Edwards W, Cooper Jr L, Sobonya R, Thompson V . Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation. 2012; 127(1):39-47. DOI: 10.1161/CIRCULATIONAHA.112.128900. View

18.

Arai H, Kuroda S, Yoshioka K, Mizukami A, Matsumura A . Images of atrial giant cell myocarditis. Eur Heart J Cardiovasc Imaging. 2017; 19(2):243. DOI: 10.1093/ehjci/jex261. View

19.

James O, Christensen J, Wong T, Borges-Neto S, Koweek L . Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics. 2011; 31(5):1271-86. DOI: 10.1148/rg.315105222. View

20.

Larsen B, Al-Badri K, Mellemkjaer S, Baerentzen S, Oxlund C, Pryds K . Inflammatory-mediated atrial cardiomyopathy diagnosed using multimodality imaging and successfully treated with prednisolone: a case report. Eur Heart J Case Rep. 2024; 8(4):ytae167. PMC: 11181939. DOI: 10.1093/ehjcr/ytae167. View